An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India

The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019

A World Trade Organisation dispute panel ruled on October 31 that India's key export promotion schemes violated WTO rules and hence should be withdrawn within six months

Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year

Why India dithers on the mega trade deal

The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight

Drug firm Strides Pharma Science on Monday said its step down subsidiary Strides Pharma Global, Singapore (SPG) has entered into a joint venture with Sun Moral International, a wholly-owned subsidiary of China's Sihuan Pharmaceutical Holdings Group, one of Chinas leading pharmaceutical companies.

Strides and Sihuan Pharmaceutical will set up a new JV company based in Hong Kong to be christened as Sihuan Strides HK Ltd; Strides will license four products immediately to this JV with an option to expand the portfolio subsequently

Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years

Indian companies are finally getting down to cracking the Japanese market

Failed policies cause domestic manufactures to import medical devices, while the government wants India to list among top five medical devices manufacturing hubs in the world under the 'Make in India' initiative

The path to product and profitability for stem cell players is fraught with challenges

Share Market Updates: Suzlon, Justdial, Infibeam, DCM Shriram and Adani Power were the top gainers on BSE, while on NSE, YES Bank, Bharti Airtel, NTPC, TCS and Bajaj Finance were the top gaining stocks.

The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases

Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.